Replimune disagrees with the FDA about whether the data set, upon which breakthrough therapy designation was awarded, is sufficient to allow this promising medicine to be made available to advanced ...

Replimune Group, Inc. stock drops after a second FDA rejection for RP1 melanoma; cash runway <12 months. Click for more on ...

Replimune (REPL) stock crashed 19% after FDA rejected RP1 melanoma treatment for second time, citing trial design issues.

Replimune (REPL) stock plunged 19% after FDA issued second rejection of RP1 melanoma immunotherapy, citing inadequate trial ...

The U.S. Food and Drug Administration (FDA) on Friday concluded that Replimmune Group Inc. REPL Biologics License Application (BLA) for vusolimogene oderparepvec in combination with nivolumab does not ...

The decision, which has been a flashpoint in an ongoing debate about regulatory flexibility, was made because Replimune ...

The Food and Drug Administration rejected Replimune Group's application for an advanced melanoma drug for a second time.

The free Tubi TV video streamer now integrates with ChatGPT so you can ask the AI to search the site's lineup of more than ...

PCWorld explains how to disable Windows 11’s numerous AI features, including Copilot, Windows Recall, and Click To Do, which are scattered across different settings menus. These AI integrations affect ...

Sunset Visitor is back with Prove You're Human, a narrative-driven sci-fi game that forces players to confront their feelings ...

The Pi Picos are tiny but capable, once you get used to their differences.

Replimune Group Inc. research and ratings by Barron's. View REPL revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.